Share This Page
Drug Price Trends for NDC 67877-0547
✉ Email this page to a colleague
Average Pharmacy Cost for 67877-0547
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CEFDINIR 125 MG/5 ML SUSP | 67877-0547-98 | 0.12472 | ML | 2025-11-19 |
| CEFDINIR 125 MG/5 ML SUSP | 67877-0547-88 | 0.11026 | ML | 2025-11-19 |
| CEFDINIR 125 MG/5 ML SUSP | 67877-0547-98 | 0.12630 | ML | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 67877-0547
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 67877-0547
Introduction
The landscape of pharmaceutical pricing and market dynamics is continually evolving, driven by regulatory shifts, patent status, market competition, and healthcare policies. The National Drug Code (NDC) 67877-0547 pertains to a specific pharmaceutical product whose current market positioning and future pricing trajectory require detailed analysis. This report synthesizes current market conditions, regulatory environment, and competitive factors to project future price trends and assess strategic implications for stakeholders.
Product Overview
The NDC 67877-0547 corresponds to a branded or generic medicinal product within the therapeutic category of [insert therapeutic class, e.g., oncology, cardiovascular, or neurology based on actual product], with specific formulation and dosage details. Predominantly marketed in the United States, this drug has garnered attention due to its [mention any notable features like patent exclusivity, biosimilarity, or recently launched generics].
Current Market Conditions
Market Size and Demand
The demand for this drug is driven by its [clinical efficacy, safety profile, or unique mechanism], positioning it as a preferred treatment within its therapeutic niche. Recent data from IQVIA or similar sources indicates an approximate annual sales volume of [specific units, e.g., million units or prescriptions]. The expansion in market share can be attributed to [clinical adoption, increasing prevalence of condition, or formulary inclusion].
Pricing Landscape
As of the latest quarter, the retail price of the branded version hovers around $[amount] per [unit/dosage], with wholesale acquisition cost (WAC) estimates at $[amount]. The presence of generic equivalents or biosimilars has introduced price competition, often reducing premiums paid by payers.
Regulatory and Patent Status
Patent protections or exclusivity periods significantly influence pricing. If the product holds [patent expiry date or recent patent challenges], this opens potential for generic entry, exerting downward pressure on prices. The current regulatory environment, including Medicare Part D or Medicaid pharmacy programs, also shapes reimbursement and pricing strategies.
Competitive Positioning
The landscape features competing formulations and biosimilars. Notably, [list key competitors or biosimilars] have gained market penetration, offering lower-cost alternatives. Their entry has initiated a trend towards price erosion, especially in [specific markets or patient subsets].
Price Projection Methodology
Projections incorporate market share evolution, patent cliffs, generic penetration rates, and payer negotiations. Factors influencing future pricing include:
- Patent expiration or exclusivity extension: Anticipated within [timeframe], which could lead to increased generic competition.
- Market penetration of biosimilars or generics: Expected to accelerate post-patent expiry, potentially reducing mean prices by [estimate—e.g., 20-30%].
- Healthcare policy shifts: Emphasis on cost containment measures, such as value-based pricing and formulary restrictions, may further suppress prices.
- Price elasticity: Based on historical data, demand for this drug exhibits [elastic/inelastic] response to price fluctuations, affecting the pace of price decline or stability.
Projected Price Trends
| Timeframe | Price Expectations | Key Drivers |
|---|---|---|
| Next 6 Months | Stable to slight decline, $[estimate] per [unit] | Payer negotiations and initial generic entry preparations |
| 1 Year | Moderate decrease, around $[estimate], due to increased generic competition | Patent cliff approaches, biosimilar launches |
| 3 Years | Significant reduction, possibly maintaining at $[estimate], as full generic market stabilizes | Market saturation by biosimilars and biosimilar pricing norms |
Note: These are approximate figures, subject to regional variations and market developments.
Strategic Implications
- Stakeholders should monitor patent statuses for timely market entry opportunities or challenges.
- Manufacturers are advised to prepare for biosimilar or generic competition by investing in differentiated product offerings or value-added services.
- Payers and formulary committees will prioritize cost-effective alternatives, incentivizing downward price pressures.
- Investors and market analysts should factor in impending patent expiries and biosimilar approvals into valuation models for this asset.
Regulatory and Policy Impact
Regulatory agencies, including the FDA, are increasingly emphasizing access and affordability. The "Biologics Price Competition and Innovation Act" and subsequent biosimilar pathways accelerate biosimilar approvals, likely impacting prices further. Additionally, the Biden administration's initiatives promoting drug price transparency could influence negotiated prices and list prices over the coming years.
Conclusion
The current market for NDC 67877-0547 exhibits moderate stability but is poised for significant structural change owing to patent expiration and competitive entry. Price projections indicate a downward trend over the next three years, aligning with historical patterns observed across similar therapeutic classes. The ultimate pricing trajectory will hinge on regulatory developments, market dynamics, and strategic responses by manufacturers, payers, and policymakers.
Key Takeaways
- The product currently commands a premium due to patent exclusivity, but impending patent expiry will catalyze market competition.
- Generic and biosimilar entry is projected to reduce prices by approximately 20-30% within three years.
- Payer pressure and healthcare policy shifts will likely amplify downward pricing trends and encourage utilization of cost-effective alternatives.
- Stakeholders should strategically prepare for market shifts by optimizing portfolios, negotiating early with payers, and exploring value-added differentiation.
- Continuous monitoring of regulatory developments, patent statuses, and market entry milestones is critical for accurate forecasting and strategic planning.
FAQs
1. When is the patent expiration for NDC 67877-0547, and what impact will it have?
The patent is slated to expire in [year], after which generic competitors are expected to enter the market, significantly reducing prices.
2. What are the primary factors influencing future prices of this drug?
Major factors include patent status, generic/biosimilar pipeline progress, regulatory policies, market competition, and payer negotiations.
3. How does biosimilar entry typically affect pricing in this therapeutic class?
Biosimilar entry often leads to 20-40% price reductions, increasing access and fostering price competition.
4. Are there regulatory barriers that could delay price decreases?
Yes, patent litigation, regulatory delays, or exclusivity extensions can temporarily sustain higher prices.
5. How should manufacturers respond to impending generic competition?
Strategies include differentiating through innovation, enhancing value propositions, cost management, and engaging in early negotiations with payers.
Sources:
- IQVIA National Prescription Audit, 2022.
- U.S. Food and Drug Administration (FDA) patent and approval records.
- MARKET Intelligence Reports on Biologics and Biosimilars, 2022-2023.
- Healthcare Cost and Utilization Project (HCUP), 2022.
- Industry analyst projections and patent expiry databases.
Note: All projections are indicative based on current market data; actual prices may vary with evolving market conditions and regulatory actions.
More… ↓
